Skip to content

Validity and Reliability Study of the Pain Indicator Behavior Scale-Brain Damage (ESCID-DC)

Validity and Reliability Study of the Pain Indicator Behavior Scale Adapted to Measure Pain in Critically Ill Patients With Acquired Brain Damage, Non-communicative and With an Artificial Airway (ESCID-DC).

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04898491
Acronym
ESCID-DC
Enrollment
300
Registered
2021-05-24
Start date
2022-06-01
Completion date
2025-06-30
Last updated
2025-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behavior, Brain Injuries, Pain

Keywords

Pain, Brain injury, Brain damage, Intensive Critical Unit, Nursing

Brief summary

A multicentre observational study to validate the adaptation of the Pain Indicator Behavior Scale (ESCID) for patients with acquired Brain Damage (ESCID-DC), as a measuring instrument.

Detailed description

Non-commercial study. The study complies with the ethical principles of the Declaration of Helsinki, the recommendations of Good Clinical Practice (GCP) and current legislation. The study has been approved with a favorable opinion by the CEIm of the Hospital Universitario 12 de Octubre. Written consent will be requested from the participants and / or their relatives / representatives to participate in the study.

Interventions

OTHERPain assessment using a behavioral scale

The pain of the subjects will be evaluated by two independent observers and with a blind result between them, coinciding with the application of two painful procedures used in routine practice: suction of tracheal secretions and the pressure in the nail bed by means of a pressure algometer. In addition, a painless procedure will also be performed to establish an element of control with the procedures painful. This will consist of the application of gentle friction with a cloth gauze, on a part of healthy skin tissue of the patient. The measurement will be performed twice for each patient and procedure depending on the level of sedation, so that the first measurement will be performed with a deeper sedation level and the second with a change in sedation level to moderate-mild. In turn, the pain assessment will be carried out in three moments: first or baseline measurement, during the application of the painless and 15 minutes after finishing the procedures.

Sponsors

Instituto de Salud Carlos III
CollaboratorOTHER_GOV
Candelas Lopez Lopez
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age equal to or greater than 18 years. 2. Inability to communicate verbally or motor. 3. Have a artificial airway. 4. Informed consent of the family member or representative of the patient.

Exclusion criteria

1. Previous pathology of cognitive impairment. 2. Previous brain injury. 3. Previous psychiatric disorder. 4. Previous dementia. 5. Previous chronic substance abuse. 6. Previous chronic diabetics. 7. Previous spinal cord injury. 8. Previous severe polyneuropathy (diagnosed or suspected). 9. Confirmed diagnosis of brain death. 10. Continuous infusion of muscle relaxants and / or barbiturate coma. 11. Level of deep sedation (RASS -5).

Design outcomes

Primary

MeasureTime frameDescription
To assess the construct validity and the reliability30 monthsNumber of patients with Brain Damage, non-communicative and artificial airway that manifest pain behaviors included in the Pain Indicator Behavior Scale-Brain Damage

Secondary

MeasureTime frameDescription
To assess pain from different procedures with ESCID-DC scale30 monthsPain score of patients before, during and after performing two procedures documented as painful (aspiration of tracheal secretions and application of pressure to the nail bed), common in the routine care of critically ill patients, and a procedure not painful (gentle friction with a cloth gauze on skin tissue) using the Indicator Behavior Scale of Pain in a Patient with Brain Damage (ESCID-DC)
To assess pain from different procedures with NCS-R scale30 monthsPain score of patients before, during and after performing two procedures documented as painful (aspiration of tracheal secretions and application of pressure to the nail bed), common in the routine care of critically ill patients, and a procedure not painful (gentle friction with a cloth gauze on skin tissue) using the Nociception Coma Scale-Revised (NCS-R)
To analyze the scale under different etiology of brain damage30 monthsPain score of patients with different etiology of brain damage (ischemic, traumatic and / or post-anoxic encephalopathy)
To analyze the scale under different levels of consciousness30 monthsPain score of patients with different levels of consciousness (severe: Glasgow Coma Score \<9 / moderate: Glasgow Coma Score 9-13 / mild: Glasgow Coma Score 14-15)
To analyze the scale under different degrees of sedation30 monthsPain score of patients with different degrees of sedation (deep sedation: Richmond Agitation-Sedation Scale (RASS) Score -5, -4 / moderate sedation: Richmond Agitation-Sedation Scale (RASS) Score -3 and/or light sedation Richmond Agitation-Sedation Scale (RASS) Score -2, -1)

Countries

Spain

Contacts

Primary ContactCandelas López-López, PhD
candelas.lopez@salud.madrid.org+34 917792634
Backup ContactSantiago Pérez-García, PhD
sperezg@salud.madrid.org+34 917792689

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026